Tim Pearson

Insider profile

Performance

Overall performance
3.3

Performance over holding periods
3.3
30 days 90 days 120 days
Average return 67% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Tim Pearson's trades of Crescent Biopharma, Inc.'s stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
245.50
Quantity 93,134 -28.9%
Value US$4,758,365
Transaction date
Planned sale
Price
469.99
Quantity 18,910 -23.8%
Value US$2,345,120
Transaction date
Planned sale
Price
125.60
Quantity 91,273 -47.0%
Value US$822,943
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-11-14 2022-11-11 B Purchase
93,134 -28.9%
245.50
US$4,758,365
93,134 -28.9% 245.50 US$4,758,365
2018-03-05 2018-03-02 PlS Planned sale
18,910 -23.8%
469.99
US$2,345,120
18,910 -23.8% 469.99 US$2,345,120
2017-03-03 2017-03-02 PlS Planned sale
91,273 -47.0%
125.60
US$822,943
91,273 -47.0% 125.60 US$822,943